Search results
First Advanced Oral Treatment For Asthma - Sanofi's Investigational Drug Shows Potential
Benzinga via Yahoo Finance· 8 hours agoWednesday, Sanofi SA (NASDAQ:SNY) reported results from the Phase 2 study of oral rilzabrutinib in...
GSK Studies on Depemokimab for Severe Asthma Meet Primary Goals
Zacks via Yahoo Finance· 12 hours agoGSK’s GSK two-phase III studies, which evaluated depemokimab for treating severe asthma...
Eosinophilic Asthma
Health via Yahoo News· 4 days agoConsider the following: Being 35-50 years old Having a personal or family history of asthma or other allergic conditions Smoking tobacco Diagnosis If you...
Manage Your Asthma: FDA on Know Your Triggers and Treatment Options
Sierra Sun Times· 2 days agoAsthma is a chronic lung disease that causes the airways to become inflamed and narrow. Symptoms of...
GSK's Experimental Asthma Drug Reduces Severe Attacks, Phase 3 Trial Data Shows
Benzinga via Yahoo Finance· 2 days agoTuesday, GSK plc (NYSE:GSK) released headline results from the phase III clinical trials SWIFT-1 and...
Research finds few moderate or severe asthma patients prescribed recommended inhaler regimen
Medical Xpress· 1 day agoIn the United States, ICS-formoterol inhalers include Symbicort (budesonide-formoterol) and Dulera...
Asthma Triggers In Homes Can Send Kids to the ER—This Organization Is Working to Change That
Health.com· 2 days agoFor parents of children with asthma, witnessing an attack of severe symptoms can be a terrifying...
GSK Sees Positive Results for Severe Asthma Treatment Depemokimab
Market Watch· 2 days agoBy Najat Kantouar GSK said that it had positive results from phase III trials of depemokimab, aimed at assessing the drug's efficacy and safety in adults and...
GSK says its experimental drug reduced asthma attacks with only two doses a year
Quartz· 1 day agoPeople suffering from a severe form of asthma could soon see their symptoms improve with a new...
GSK boasts win for depemokimab in asthma trials
Clinical Trials Arena via Yahoo Finance· 2 days agoThe two randomised, multi-centre, placebo-controlled trials investigated depemokimab in adults and adolescents with severe asthma with type 2...
